Cancer Research Meeting Calendar  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wieckowski, E.
Right arrow Articles by Rabinowich, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wieckowski, E.
Right arrow Articles by Rabinowich, H.
[Cancer Research 62, 4884-4889, September 1, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Granzyme B-mediated Degradation of T-Cell Receptor {zeta} Chain1

Eva Wieckowski, Gui-Qiang Wang, Brian R. Gastman, Leslie A. Goldstein and Hannah Rabinowich2

Departments of Pathology [E. W., G-Q. W., L. A. G., H. R.], and Otolaryngology [B. R. G.], The University of Pittsburgh School of Medicine, and The University of Pittsburgh Cancer Institute [H. R.], Pittsburgh, Pennsylvania 15213

We recently reported that the T-cell receptor (TCR)-{zeta} chain is cleaved bycaspase-3 and -7 in apoptotic T lymphocytes or in a cell-free system. Wereport here that the {zeta} chain is also a direct substrate for granzyme B (GrB) proteolytic activity. Loss in expression of TCR-{zeta} was observed in Jurkat T leukemic cells treated by a combination of GrB and a replication-deficient adenovirus. Although the apoptosis initiated in these cells by GrB was significantly reduced by the pancaspase inhibitor Z-VAD-FMK, TCR-{zeta} degradation was not prevented. These findings suggest that the GrB-mediated degradation of TCR-{zeta} chain can proceed despite the efficient inhibition of caspase activity. An in vitro translated TCR-{zeta} product was efficiently cleaved by GrB, which suggests that the TCR-{zeta} protein is a direct substrate for GrB. As assessed by site-directed mutagenesis, the activity of GrB was directed toward aspartic acid residues that were different from those of recombinant caspase-3. Whereas caspase-3 cleavage products appear to accumulate, the GrB-generated products seem to undergo further degradation, which suggests the presence of multiple GrB-specific cleavage sites within the TCR-{zeta} protein. These findings suggest that the TCR-{zeta} protein in target T lymphocytes serves as a substrate for the proteolytic activities that are featured by the two major mechanisms of cytotoxicity: death receptor pathways mediated by caspases and granule exocytosis mediated by direct GrB activity or GrB-activated caspases. TCR-{zeta} protein degradation may be of significance in cytotoxic mechanisms directed against T cells infected with viruses, such as HIV-1, in which the TCR-{zeta} protein is used for viral pathogenesis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. L. Gorman, A. I. Russell, Z. Zhang, D. Cunninghame Graham, A. P. Cope, and T. J. Vyse
Polymorphisms in the CD3Z Gene Influence TCR{zeta} Expression in Systemic Lupus Erythematosus Patients and Healthy Controls
J. Immunol., January 15, 2008; 180(2): 1060 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ganor, V. I. Teichberg, and M. Levite
TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage
J. Immunol., January 15, 2007; 178(2): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. von Essen, C. M. Bonefeld, V. Siersma, A. B. Rasmussen, J. P. H. Lauritsen, B. L. Nielsen, and C. Geisler
Constitutive and Ligand-Induced TCR Degradation
J. Immunol., July 1, 2004; 173(1): 384 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Han, L. A. Goldstein, B. R. Gastman, C. J. Froelich, X.-M. Yin, and H. Rabinowich
Degradation of Mcl-1 by Granzyme B: IMPLICATIONS FOR Bim-MEDIATED MITOCHONDRIAL APOPTOTIC EVENTS
J. Biol. Chem., May 21, 2004; 279(21): 22020 - 22029.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Clark, A. E. Annenkov, M. Panesar, P. Isomaki, Y. Chernajovsky, and A. P. Cope
T cell receptor {zeta} reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor {alpha}
PNAS, February 10, 2004; 101(6): 1696 - 1701.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.